Good morning, and welcome to the 2026 Annual Meeting of Stockholders of Arcturus Therapeutics Holdings, Inc. We are holding this year's annual meeting as an entirely virtual meeting. Stockholders who ...

The Japanese drugs giant Takeda and the US biotech Arcturus Therapeutics have joined the hunt for therapies for the COVID-19 coronavirus. As the infection and death count continues to rise across the ...

Japan’s medicines regulator has approved the first vaccine based on self-assembling RNA, a spin on the mRNA technology used in current shots, which is designed to deliver greater efficacy with a lower ...

Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a ...

The Staff Selection Commission (SSC) will soon release the SSC GD Answer Key on its official website ssc.gov.in. The SSC conducted the General Duty (GD) exam from April 27, 2026 to May 30, 2026. After ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Most G-Shock watches offer excellent value. Stupid tough, highly legible, incredibly useful, sometimes colorful and often on sale — no collection is complete without at least one G-Shock, if not ...

Arcturus—a clinical-stage mRNA therapeutics and vaccines company With its unique mRNA therapeutics platform, Arcturus Therapeutics is a leading clinical-stage mRNA medicines company focused on the ...

About Arcturus Therapeutics Holdings Inc. Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious ...